Clinical trial
A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder
NCT00470483 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00470483 |
|---|---|
| Title | A Study To Compare Emotional Changes In Subjects With Social Anxiety Disorder |
| Official title | A Double-Blind, Randomized, Placebo-Controlled, Parallel Group, fMRI and PET Study Comparing Emotional Challenge-induced Regional Cerebral Blood Flow Changes Before and After 8 Weeks of Treatment With Placebo and Paroxetine in Subjects With Social Anxiety Disorder |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Social Phobia |
| Intervention type | Drug |
| Interventions | Placebo treatment during 8 weeks, Paroxetine treatment during 8 weeks |
| Enrollment | 56 |
| Start date | Jan 22, 2007 |
| Primary completion | Jan 7, 2009 |
| Completion | Jan 7, 2009 |
| First posted | May 7, 2007 |
| Last update posted | Jul 18, 2017 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: